Cannabinoids Ease Motor Symptoms in Mouse Model of Parkinson’s, Early Results Show
Cannabinoid-based formulations in development at GB Sciences were able to ease behavioral symptoms linked to the loss of dopamine…
Articles by Patricia Inácio, PhD
Patient Treatment Completed in Phase 1/2 Trial Testing Therapy Candidate CDNF in Parkinson’s Disease
Patient treatment has been completed in a Phase 1/2 clinical trial testing cerebral dopamine neurotrophic factor (CDNF) for…
Gosuranemab Fails to Show Efficacy in Phase 2 Progressive Supranuclear Palsy Trial
Gosuranemab failed to meet its primary and key secondary goals in a Phase 2 study evaluating its use in treating …
New Gene Therapy Delivery Method May Open BRAVE New World in Parkinson’s Research
A new method allows researchers to develop adeno-associated virus (AVV) — commonly used as the vehicle for gene therapies —…
3D Structure of Brain Alpha-Synuclein More Heterogeneous Than Previously Thought, New Study Reports
Clumps, or aggregates of alpha-synuclein protein in the brain, a hallmark of Parkinon’s disease, are more heterogeneous than…
First DUB Enzymes Identified by Partnership as Potential Therapeutic Targets for Parkinson’s and Alzheimer’s
Mission Therapeutics and AbbVie have identified several molecules, called deubiquitylating enzymes, or DUBs, that may be potential therapeutic…
Dosing Begins in Phase 2 Trial of CNM-Au8, Potential Therapy for Dopaminergic Neurons
A pilot Phase 2 study evaluating CNM-Au8, an investigational Parkinson’s treatment aiming to protect nerve cells, has started dosing patients,…
RightEye’s Vision System for Early Diagnosis Named ‘Breakthrough Device’ by FDA
RightEye’s Vision System, an advanced eye-tracking device that measures eye tremors to help diagnose Parkinson’s disease…
Sunovion Re-Submits Approval Request for APL-130277 to FDA for Treating Parkinson’s Off Periods
Sunovion Pharmaceuticals has re-submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA), once…
Gut Inflammation May Increase Risk for Parkinson’s Disease, Review Study Suggests
Inflammation in the gut, a hallmark of autoimmune disorders such as inflammatory bowel disease, may contribute to an earlier…